Amgen announced that EVENITY, or romosozumab-aqqg, is now available for shipment to wholesalers in the U.S. EVENITY was approved by the FDA on April 9 for the treatment of osteoporosis in postmenopausal women at high risk for fracture. Osteoporosis is a serious, chronic condition with no cure.
https://thefly.com/landingPageNews.php?id=2892761
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.